pinocembrin has been researched along with Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cui, M; Cui, Y; Gan, W; Helian, K; Li, X; Liu, R; Ning, W; Ren, S; Wang, M; Wei, Y; Xiao, T; Yang, C; Zhou, H | 1 |
1 other study(ies) available for pinocembrin and Pneumonia
Article | Year |
---|---|
Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Flavanones; Inflammasomes; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4 | 2021 |